Company Filing History:
Years Active: 2018
Title: The Innovative Contributions of Darcy Bates
Introduction
Darcy Bates is a notable inventor based in White River Junction, VT (US). She has made significant contributions to the field of medicine, particularly in the treatment of chronic lymphocytic leukemia (CLL). With a total of 2 patents, her work is paving the way for new therapeutic approaches.
Latest Patents
Darcy Bates holds two recent patents that focus on innovative methods for treating CLL. The first patent, titled "Combination treatment protocol," provides a comprehensive method for treating chronic lymphocytic leukemia. The second patent, "Method for treating chronic lymphocytic leukemia," outlines specific methods utilizing medicaments that can be pharmaceutical compositions or kits. Notably, the compounds involved include 2-methyl-7-hydroxy-3-(3,4,5-trimethoxybenzoyl)-6-methoxybenzofuran, known as BNC105, and disodium 6-methoxy-2-methyl-3-(3,4,5-trimethoxybenzoyl)benzofuran-7-yl phosphate, referred to as BNC 105P.
Career Highlights
Darcy Bates is currently associated with Bionomics Inc., where she continues to develop her innovative ideas. Her work is characterized by a strong focus on improving treatment protocols for patients suffering from CLL.
Collaborations
Throughout her career, Darcy has collaborated with esteemed colleagues such as Alan R Eastman and Gabriel Kremmidiotis. These partnerships have enhanced her research and contributed to the advancement of her patented methods.
Conclusion
Darcy Bates is a pioneering inventor whose work in the treatment of chronic lymphocytic leukemia is making a significant impact in the medical field. Her innovative patents and collaborations reflect her dedication to improving patient outcomes.